Abeona Therapeutics Inc. (ABEO): Price and Financial Metrics

Abeona Therapeutics Inc. (ABEO)

Today's Latest Price: $3.01 USD

0.34 (-10.15%)

Updated Jul 10 4:00pm

Add ABEO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ABEO Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ABEO is -0.02 -- better than only 6.6% of US stocks.
  • ABEO's went public 34.25 years ago, making it older than 92.52% of listed US stocks we're tracking.
  • Revenue growth over the past 12 months for Abeona Therapeutics Inc comes in at -139.84%, a number that bests merely 0.35% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to ABEO, based on their financial statements, market capitalization, and price volatility, are HTBX, CRIS, ALBO, ADRO, and VTVT.
  • ABEO's SEC filings can be seen here. And to visit Abeona Therapeutics Inc's official web site, go to www.abeonatherapeutics.com.
ABEO Daily Price Range
ABEO 52-Week Price Range

ABEO Stock Price Chart Technical Analysis Charts

ABEO Price/Volume Stats

Current price $3.01 52-week high $5.19
Prev. close $3.35 52-week low $1.35
Day low $2.90 Volume 1,840,975
Day high $3.27 Avg. volume 1,414,236
50-day MA $2.97 Dividend yield N/A
200-day MA $2.76 Market Cap 251.93M

Abeona Therapeutics Inc. (ABEO) Company Bio

Abeona Therapeutics Inc. focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company iwas founded n 1989 and is based in Dallas, Texas.

ABEO Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ABEO Latest Social Stream

Loading social stream, please wait...

View Full ABEO Social Stream

Latest ABEO News From Around the Web

Below are the latest news stories about Abeona Therapeutics Inc that investors may wish to consider to help them evaluate ABEO as an investment opportunity.

Abeona Therapeutics Announces Two Presentations Related to Its RDEB Clinical Program at the Society for Pediatric Dermatology 45th Annual Meeting

EB-101 treatment of large, chronic wounds is associated with durable healing and pain relief in patients with RDEBLiterature review of 65 studies confirms and expands.

Yahoo | July 10, 2020

Abeona Therapeutics names new commercial chief

Abeona Therapeutics ([[ABEO]] +0.9%) appoints Michael Amoroso as Senior Vice President and Chief Commercial Officer, effective immediately.Previously, he served as SVP and Head of Worldwide Commercial, Cell Therapy at Gilead's Kite Pharma....

Seeking Alpha | July 9, 2020

Abeona Restarts Enrollment in Connective Tissue Disorder Study

Abeona (ABEO) restarts patient enrollment in phase III VIITAL study of EB-101 for the treatment of recessive dystrophic epidermolysis bullosa.

Yahoo | July 9, 2020

Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Commercial Officer

NEW YORK and CLEVELAND, July 09, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Michael.

Yahoo | July 9, 2020

Abeona resume enrollment in late-stage study of gene therapy in rare skin blistering disorder

Emerging from the temporary pause due to COVID-19 disruptions, Abeona Therapeutics (ABEO) has restarted enrollment in its pivotal Phase 3 clinical trial, VIITAL, evaluating gene therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa ((RDEB)), a rare inherited disorder characterized by fragile skin that blisters easily.On another note, its two...

Seeking Alpha | July 8, 2020

Read More 'ABEO' Stories Here

ABEO Price Returns

1-mo 2.38%
3-mo 15.77%
6-mo 14.02%
1-year -27.99%
3-year -67.63%
5-year -50.17%
YTD -7.95%
2019 -54.20%
2018 -54.95%
2017 226.80%
2016 44.35%
2015 -2.61%

Continue Researching ABEO

Want to see what other sources are saying about Abeona Therapeutics Inc's financials and stock price? Try the links below:

Abeona Therapeutics Inc (ABEO) Stock Price | Nasdaq
Abeona Therapeutics Inc (ABEO) Stock Quote, History and News - Yahoo Finance
Abeona Therapeutics Inc (ABEO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0836 seconds.